Gsk (GSK) Depreciation and Depletion (2009 - 2015)

Gsk's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $1.4 billion for Q4 2015.

• In Q4 2015, Depreciation and Depletion rose 9.53% year-over-year to $1.4 billion; the TTM figure through Dec 2015 stood at $5.2 billion (down 0.95% YoY), while the FY2018 annual figure was $1.3 billion, changed 0.11% from the prior year.
• Depreciation and Depletion for Q4 2015 stood at $1.4 billion, up from $1.2 billion in the prior quarter.
• The five-year high for Depreciation and Depletion was $1.4 billion in Q4 2011, with the low at $1.2 billion in Q4 2013.
• The 5-year median for Depreciation and Depletion is $1.4 billion (2015), against an average of $1.3 billion.
• The sharpest annual moves came in 2011 and 2015: Depreciation and Depletion dropped 22.49% in 2011, then grew 9.53% in 2015.
• Gsk's Depreciation and Depletion stood at $1.4 billion in 2011, then dropped by 0.33% to $1.4 billion in 2012, then retreated by 15.27% to $1.2 billion in 2013, then gained by 4.28% to $1.2 billion in 2014, then increased by 9.53% to $1.4 billion in 2015.
• Business Quant data shows GSK's Depreciation and Depletion at $1.4 billion in Q4 2015, $1.2 billion in Q4 2014, and $1.2 billion in Q4 2013.